Ignite Creation Date:
2024-05-05 @ 11:28 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01337336
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2011-04-15
Brief Title:
Chronic Obstructive Pulmonary Disease COPD-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 25050mcg Versus Anticholinergics in a COPD-Comorbid DepressionAnxiety Population
Sponsor:
Organization:
GlaxoSmithKline
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
1
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 14217 |
Who Masked List: